Merck & Co. Performance, Products, Pipeline and Potential : Market Research Report

Merck & Co. Performance, Products, Pipeline and Potential

Published by: Espicom Healthcare Intelligence

Published: Nov. 10, 2009 - 186 Pages

Breaking News: Latest Results
EXECUTIVE SUMMARY: Introduction; Current Financial Position; Company Performance; Business Segment Performance; Geographic Segment Performance; Company Strategy; R&D Strategy; Mergers, Acquisitions and Divestitures; Key Agreements; Discontinued Agreements; Production; Employees; Product Performance Forecasts; Pipeline Analysis; Discontinued Projects; Other Factors Affecting the Bottom Line; Conclusions
THERAPEUTIC AREA FOCUS
R&D PIPELINE
CARDIOVASCULAR: Marketed Products; Cordaptive/Tredaptive; Cozaar/Hyzaar; Vytorin/Inegy; Zetia/Ezetrol; Zocor; Others; R&D Projects; Anacetrapib; MK-0524B; Rolofylline; Vernakalant; Growth Forecast
RESPIRATORY: Marketed Products; Singulair; R&D Projects; MK-2295; Growth Forecast
VACCINES: Marketed Products; Gardasil; Hexavac; ProQuad; RotaTeq; Zostavax; Others; R&D Projects; Flu Micro-Injection; V419; V503; V710; V930; V934/V935; V950; Growth Forecast
ANTI-INFLAMMATORY: Marketed Products; Fosamax; Others; R&D Projects; JTT-305; Odanacatib; Growth Forecast
METABOLIC: Marketed Products; Januvia/Janumet; R&D Projects; MK-0893; Growth Forecast
ANTIBACTERIALS/ANTIFUNGALS: Marketed Products; Cancidas/Caspofungin MSD; Others; R&D Projects; Cubicin; MK-7009; Growth Forecast
OPHTHALMOLOGICAL: Marketed Products; Trusopt/Cosopt; Others; Growth Forecast; HIV; Marketed Products; Isentress; Others; R&D Projects; CMPD167; L'644; Growth Forecast
NEUROLOGY: Marketed Products; Maxalt; R&D Projects; Telcagepant; Growth Forecast
UROLOGY: Marketed Products; Proscar; Growth Forecast
ONCOLOGY: Marketed Products; Zolinza; R&D Projects; AGS-PSCA; MK-0646; Ridaforolimus; Growth Forecast
OTHERS: Marketed Products; R&D Projects; MK-677; Ostarine
APPENDIX 1 - FINANCIAL PERFORMANCE: Full Year Results 2008
APPENDIX 2 - KEY CORPORATE EVENTS
APPENDIX 3 - KEY AGREEMENTS: Actelion Pharmaceuticals Ltd; Acumen Pharmaceuticals; Addex Pharmaceuticals Ltd; Advinus Therapeutics; Agensys Inc; Allergan; Ambrx Inc; Arena Pharmaceuticals Inc; ARIAD Pharmaceuticals; AstraZeneca; Biovail Corporation; BioXell SpA; Cardiome Pharma; Celera Genomics Group; Chiron Corporation; Cima Labs; Coley Pharmaceutical; Covance Inc; Crucell NV; CSL Biotherapies; Cubist Pharmaceuticals; Dana-Farber Cancer Institute; deCODE genetics; Depomed Inc; Galapagos NV; Génome Québec; Geron Corporation; Gilead Sciences; Gladstone Institute; GlaxoSmithKline; GTx Inc; Idera Pharmaceuticals; Inovio Biomedical Corporation; Intercell AG; International Partnership for Microbicides; Iroko Pharmaceuticals LLC; Japan Tobacco Inc; Kinemed Inc; Kyowa Hakko Kirin; Kyorin Pharmaceutical Co Ltd; Lundbeck; Marcadia Biotech; Medarex/Massachusetts Biological Laboratories; Medicure Inc; Metabasis Therapeutics Inc; Monogram Biosciences; Neurogen Corporation; NicOx SA; Ono; Paratek Pharmaceuticals; Pierre Fabre Group; PPD Inc; Portola Pharmaceuticals Inc; Ranbaxy Laboratories; Rigel Pharmaceuticals Inc; Santen Pharmaceutical; Schering-Plough; Scynexis Chemistry & Automation Inc; Sunesis Pharmaceuticals Inc; Taisho Pharmaceutical Co Ltd; Transgene SA; UCB; Vertex Pharmaceuticals Inc; Vical Incorporated; Xenon Pharmaceuticals Inc; Others
APPENDIX 4 - INFRASTRUCTURE: Research And Development Facilities; Manufacturing Facilities
APPENDIX 5 - KEY PHARMACEUTICAL SUBSIDIARIES / JOINT VENTURES: Subsidiaries; Joint Ventures
APPENDIX 6 - PRODUCT INDEX
Index of Tables: Principal Operating Results; Captial Expenditure By Function; Sales By Business Area; Sales By Geographic Area; Recent Product Approvals; Major Products, Therapeutic Areas and Sales; Major Cardiovascular Products, 2008; Major Respiratory Products, 2008; Major Vaccines 2008; Major Anti-inflammatory Products, 2008; Major Metabolic Products, 2008; Major Antibacterial/Antifungal Products, 2008; Major Ophthamological Products, 2008; Major HIV Products, 2008; Major Neurology Products, 2008; Major Urology Products, 2008; Major Oncology Products, 2008; Merial Limited Sales; Sanofi Pasteur MSD Vaccine Sales; Johnson & Johnson MSD Europe Sales
Index of Charts: Capital Expenditure By Function, 2008; Sales By Business Area, 2008; Sales By Geographic Area; Sales of Top 10 Products (2003A-2013E); Top Selling Products, 2008; Cordaptive ER Sales (2009E-2013E); Cozaar/Hyzaar Sales (2003A-2013E); Vytorin Sales (2004A-2013E); Zetia Sales (2003A-2012E); Zocor Sales (2003A-2013E); MK-0524B Sales (2009E-2013E); Singulair Sales (2003A-2013E); Gardasil Sales (2006A-2013E); RotaTeq Sales (2006A-2013E); Zostavax Sales (2006A-2013E); Fosamax Sales (2003A-2013E); Januvia Sales (2006A-2013E); Janumet Sales (2007A-2013E); Cancidas Sales (2003A-2013E); Trusopt/Cosopt Sales (2003A-2013E); Isentress Sales (2008A-2013E); Maxalt Sales (2003A-2013E); Telcagepant Sales (2010E-2014E); Proscar Sales (2003A-2013E); Zolinza Sales (2006A-2013E); Sales, Costs and Operating Income; Profitability and Research Ratios; R&D Expenditure and Capital Expenditure; Current Assets, Liabilities and Ratio; Assets, Cash and Liquidity; Employees and Productivity

Abstract

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to a complete analysis of its latest full fiscal year and an outlook for the future. A section on company strategy covers mergers, acquisitions and divestitures, key agreements, products and R&D. An overview of key products and R&D is followed by a comprehensive review of the company's product portfolio and research and development pipeline by therapeutic area. In addition, supplementary appendices provide more in-depth information on financials, agreements and corporate events.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

2/15/2012 - 32

Merck & Co. Performance, Products, Pipeline and Potential

Table of Contents

Abstract